#WorldHealthOrganization; #MSDforMothers; #FerringPharmaceuticals, #DrTedrosAdhanomGhebreyesus; #Oxytocin; #carbetocin
Ottawa, Jun 29 (Canadian-Media): According to a study led by the World Health Organization (WHO) in collaboration with MSD for Mothers and Ferring Pharmaceuticals, a new formulation of a drug can prevent excessive bleeding following childbirth and could save thousands of women’s lives in low- and lower-middle-income countries, media reports said.
Oxytocin as the first-choice drug has been recommended by WHO recently for preventing excessive bleeding after childbirth.
But Oxytocin must be stored and transported at 2–8 degrees Celsius, which is hard to do, in many countries, depriving many women of access to this lifesaving drug.
The drug, when available to these countries, loses its efficacy due to heat exposure.
The study, published June 27 in the New England Journal of Medicine, has shown an alternative drug to be as safe and effective as oxytocin in preventing postpartum haemorrhage.
This new formulation of carbetocin is heat-stable and does not require refrigeration and retains its efficacy for at least 3 years stored even at high temperatures of 30 degrees celsius and 75 percent relative humidity.
“This is a truly encouraging new development that can revolutionize our ability to keep mothers and babies alive,” says Dr Tedros Adhanom Ghebreyesus, Director-General of WHO.
Dr Tedros Adhanom Ghebreyesus. Image credit: Wikipedia
Approximately 70 000 women die every year because of post-partum haemorrhage – increasing the risk that their babies also die within one month.
The clinical trial, the largest of its kind, studied close to 30 000 women who gave birth vaginally in 10 countries: Argentina, Egypt, India, Kenya, Nigeria, Singapore, South Africa, Thailand, Uganda and the United Kingdom.
Each woman was randomly given a single injection of either heat-stable carbetocin or oxytocin immediately following the birth of her baby. The study found that both drugs were equally effective at preventing excessive bleeding after birth.
Since both drugs in the study were kept in at the temperatures required to ensure maximum efficacy of oxytocin, the trial may underestimate the benefit expected with heat-stable carbetocin use in real-life settings where oxytocin may have degraded due to exposure to higher temperatures.
“The development of a drug to prevent postpartum haemorrhage that continues to remain effective in hot and humid conditions is very good news for the millions of women who give birth in parts of the world without access to reliable refrigeration,” says Dr Metin Gülmezoglu, from the Department of Reproductive Health and Research at WHO.
The next step is regulatory review and approval by countries.
WHO will ask its Guideline Development Group to consider whether heat-stable carbetocin should be a recommended drug for the prevention of postpartum haemorrhage.
#InternationalClassificationofDiseases; #WorldHealthOrganisation; #mappinghumancondition; #traditionalmedicine, #sexualhealth; #gamingdisorder
Ottawa, Jun 22 (Canadian-Media): A new version of the International Classification of Diseases (ICD-11) has been released this week by World Health Organisation (WHO).
The ICD maps the human condition from birth to death and codes any injury or disease we encounter in life including anything we might die of.
The ICD is made up of thousands of codes that are used around the world to classify diseases and conditions, and generate statistics.
These statistics are used to monitor health trends, plan how services are delivered and make financing decisions about health systems.
The importance of ICD for global health can be clearly demonstrated from the following video:
It had taken over a decade for this electronic version of the ICD to be completed and this version of the ICD reflects progress in medicine and advances in scientific understanding.
New chapters on traditional medicine and sexual health has been added to this electronic version of the ICD and “gaming disorder” has been added to the section on addictive disorders.
The ICD provides a common vocabulary for recording, reporting and monitoring health problems in a world of 7.4 billion people speaking nearly 7000 languages.
Fifty years ago, it would be reportedly unlikely that a disease such as schizophrenia would be diagnosed similarly in Japan, Kenya and Brazil.
Now, however, if a doctor in another country cannot read a person’s medical records, they will know what the ICD code means.
Toronto, Jun 19 (Canadian-Media): Vedanda Cultural Foundation Canada in association with the Consulate General of India, Toronto, is organizing a Yoga session in Oakville, Ontario on June 23 to celebrate International Day of Yoga 2018, media reports said.
Reporting by Asha Bajaj
#DigitalHealthCoalition; #HallofFemme; #digitalandelectronicmarketing; #healthcareproductsandservices; #MM&M'sHallofFemme; #WendyBlackburn; #NadineLeonard; #MeghanRivera; #LindaRuschau; #AnneBentley, #CSweetener.org
Ottawa, June 11, (Canadian-Media): Four women leaders of The Digital Health Coalition (DHC) were inducted to the Hall of Femme last week for their hard work, leadership, and dedication to DHC, media reports said.
DHC, reportedly, a nonprofit organization was created to serve as the collective public voice and national public forum for the discussion of the current and future issues relevant to digital and electronic marketing of healthcare products and services.
The vision of DHC is reportedly to identify and then recommend specific actions that will inform digital healthcare communication and engagement for the benefit of the public at large.
MM&M's Hall of Femme reportedly honors outstanding United States (US) healthcare commercial executives at either a biopharma company, medical device or diagnostics firm, or healthcare marketing or media firm.
The four women who were inducted to the Hall of Femme last week are: Wendy Blackburn, Executive Vice President, Intouch Solutions; Nadine Leonard, Managing Director & Executive Planning Director, Heartbeat; Meghan Rivera, Vice President, Digital Engagement and Women's Health Marketing, AMAG Pharmaceuticals; and Linda Ruschau, Chief Client Officer, PatientPoint.
DHC asked Wendy about the most important aspects within a team to continue the positive path forward.
Wendy Blackburn. Image credit: Twitter handle
Wendy's reply was,
"To continue the positive path forward, we must own what we’ve earned -- and pay it forward. We must see each other, support each other, and set a strong example for future women leaders to follow. Reach out to the rising stars -- mentor and coach them. We should consider it our responsibility to help future women leaders shine, whether they are on our team, within our company, across the industry, or anywhere else. We can help them recognize and embrace their natural strengths as women. Just as others helped us."
When Nadine Leonard was asked by DHC about which transformative elements would encourage continued growth she replied,
"Healthcare is experiencing significant macro-changes as it struggles to meet the needs of bigger patient populations...So, I’d love to see pharma champion more solutions that bring physicians, patients, AND payers together to actually deliver better outcomes and added that it meant forging new ground with courage and broader skill sets and said "But we are on the cusp of making a paradigm shift from talking about efficacy to actually delivering it. That’s exciting stuff. And I’d like to see more folks up for – and honestly, EXCITED by – the challenge!"
Meghan Rivera was asked by DHC how the female leadership has facilitated pharma's mission to improve patient health outcomes.
Rivera replied that diversity in leadership, beyond gender allows for different minds, cultures and ideals to come together to achieve better solutions and added,
"At AMAG Pharmaceuticals, we’re working hard to cultivate empathy around women’s sexual health and recognize unconscious bias, to not only improve how we work together, but to also gain a greater appreciation for the barriers the patients we serve face, especially in women’s health."
DHC asked Linda Ruschau which part of her legacy she was most passionate about continuing to create.
Ruschau replied that any legacy which she may leave "comes out of my passion to make a difference in people’s lives—one at a time. Internally, that may be mentoring an entry-level Client Services young woman, or supporting a senior-level colleague making a difficult decision."
She aeeded that industry wide, she had cultivated love for her clients and felt fortunate to be in a role "that allows me to help them engage patients and physicians every day. Working with our patient advocacy partners like Imerman Angels and the Arthritis Foundation is validation that the education we provide really does make a difference in patients’ lives. Creating more innovative touchpoints to truly make doctors’ jobs easier and patients’ experience better is what excites me the most...there’s no channel more powerful than point of care to meaningfully connect with patients and providers."
Anne Bentley of the non-profit CSweetener.org -- a not-for profit organization dedicated to helping women benefit from mentorship to become the best leaders they can be -- congragulated these four woman and said, "I’m so pleased to see the Healthcare industry acknowledging these female leaders...have put in, in order to reach the top.... But I believe it’s not just about the hard work...It’s critical to have outside perspective and guidance...a key agent for advancing women forward is mentorship and added that "today, more than ever, women need mentors ...who have the experience and knowhow...and wish to give back to the help the next generation of leaders succeed.
She then said that her organization CSweetener plays a powerful role in connecting female healthcare leaders with mentors who are experienced and committed and added, "I believe it’s essential to tap into your network and to lean on your mentors for their guidance and support."